A human embryo fibroblast-derived peptide suppresses the zymosan-induced biochemical activation in human polymorphonuclear leukocytes
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 20 (1) , 41-46
- https://doi.org/10.1016/0165-2478(89)90066-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Heterogenous macrophage-activating factors from extracellular matrix of human embryo fibroblastsImmunology Letters, 1988
- Different inducing activities for cytotoxic T cells by heterogeneous thymocyte-activating factors from SV40-transformed human embryo fibroblastsImmunology Letters, 1986
- Role of protein kinases in stimulation of human polymorphonuclear leukocyte oxidative metabolism by various agonists. Differential effects of a novel protein kinase inhibitor.Journal of Clinical Investigation, 1986
- Thymocyte activating factors from SV40-transformed human embryo fibroblastsImmunology Letters, 1985
- Large-molecular-weight thymocyte-activating factors in extracellular matrix of SV40-transformed human embryo fibroblastsImmunology Letters, 1985
- Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates—in comparision with that of colchicine and various scavengersBiochemical Pharmacology, 1984
- A decrease of RNA synthesis during macrophage activation with lipopolysaccharide — an association with novel regulating factorsImmunology Letters, 1984
- An enzyme-release assay for natural cytotoxicityJournal of Immunological Methods, 1983
- Sulfones and sulfonamides in dermatology todayJournal of the American Academy of Dermatology, 1979
- Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activityBiochemical and Biophysical Research Communications, 1972